Session 16
Evolving Concepts in Dermatology Part XIII

About
Faculty
Learning Objectives
Intended Audience
Accreditation Statement
Credit Designation Statement
Disclosure
Disclaimer

The need for continued education is critical in these uncertain times. Therefore, the co-directors of the Fall Clinical Dermatology Conference are excited to announce our new program: the Fall Clinical Virtual Grand Rounds (FCVGR). This new online series is designed to help maintain the educational opportunities one would have if they were able to attend grand rounds in person.

FCVGR will consist of weekly CME sessions on a variety of dermatological diseases and tools.

This week, we will be coming to you LIVE!
Wednesday, August 5, 2020
8 PM EDT/ 5 PM PDT

EVOLVING CONCEPTS IN DERMATOLOGY PART XIII

What You Need to Know from Recent JAMA Dermatology Articles

Keeping You Up to Date: The Latest and Greatest in Dermatology

Theodore Rosen, MD

Faculty

Professor of Dermatology
Baylor College of Medicine
Chief of the VA Dermatology Service
VA Medical Center
Houston, TX

Kanade Shinkai, MD, PhD

Faculty

Professor of Dermatology
University of California San Francisco
Editor, JAMA Dermatology
San Francisco, CA

Upon completion of this activity, the participant should be better able to:

Discuss updated information about dermatologic science and practices based on recent articles published in JAMA Dermatology
Integrate use of newer anti-acne agents into daily practice
Examine the use of several existing agents, off-label, for the management of selected dermatoses

This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Institute for Continuing Healthcare Education and Dermatology University. The Institute is accredited by the ACCME to provide continuing medical education for physicians.

The Institute designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity is supported by educational grants from Almirall, Bristol-Myers Squibb, Lilly, Mayne Pharma, and UCB.

CONFLICTS OF INTEREST/DISCLOSURES

Faculty disclosures to be announced.

Kanade Shinkai, MD, PhD has disclosed that he has no relevant financial relationships specific to the subject matter witin the past 12 months.

Theodore Rosen, MD

Consultant: Bausch Health (Ortho Derm)
Advisory Board: Digitech, Foamix, Leo, Menlo

Cathy Pagano (Institute for Continuing Healthcare Education) has disclosed that she has no relevant financial relationships specific to the subject matter within the past 12 months.

[fc+290]

Session 16 Evolving Concepts in Dermatology Part XIII

Theodore Rosen, MD

Kanade Shinkai, MD, PhD

CONFLICTS OF INTEREST/DISCLOSURESFaculty disclosures to be announced.Kanade Shinkai, MD, PhD has disclosed that he has no relevant financial relationships specific to the subject matter witin the past 12 months. Theodore Rosen, MD

Cathy Pagano (Institute for Continuing Healthcare Education) has disclosed that she has no relevant financial relationships specific to the subject matter within the past 12 months.

Session 16
Evolving Concepts in Dermatology Part XIII

CONFLICTS OF INTEREST/DISCLOSURES

Faculty disclosures to be announced.

Kanade Shinkai, MD, PhD has disclosed that he has no relevant financial relationships specific to the subject matter witin the past 12 months.

Theodore Rosen, MD